Archives for March 5, 2007

← 2007

Oral strip for generic Zofran

By  Anna Lewcock

A new rapidly dissolving oral strip for ondansetron, the active ingredient in GSK's anti-emetic drug Zofran, has been developed in a Swiss-German collaboration.

Patheon to resuscitate thanks to $150m rescue

By  Emilie Reymond

Canadian contract manufacturer Patheon has announced a $150m (€114m) investment by a private equity firm - a move the company sees as the best viable option to end its financial misery.

Novo increases diabetes research in China

By  Mike Nagle

Novo Nordisk will continue to exploit the emerging importance of China in pharma research by establishing a new diabetes research foundation there.

GSK erodes pipeline across several areas

By  Mike Nagle

GlaxoSmithKline (GSK) has stopped development of several drugs, leaving some industry experts to wonder if the company's cap on research spending is stifling drug development.